
CELEOS is a deeptech company focused on revolutionizing oncological surgeries through innovative technology. Their flagship product, SpiderMass, enables contactless in situ sampling and real-time tissue characterization using mass spectrometry and AI. This approach aims to enhance surgical precision, reduce cancer relapses, and minimize environmental impact. CELEOS is dedicated to improving health outcomes while fostering sustainability, making it a compelling investment opportunity in the medical technology sector.

CELEOS is a deeptech company focused on revolutionizing oncological surgeries through innovative technology. Their flagship product, SpiderMass, enables contactless in situ sampling and real-time tissue characterization using mass spectrometry and AI. This approach aims to enhance surgical precision, reduce cancer relapses, and minimize environmental impact. CELEOS is dedicated to improving health outcomes while fostering sustainability, making it a compelling investment opportunity in the medical technology sector.
Product: SpiderMass — contactless laser sampling + mass spectrometry + explainable AI for intraoperative tissue characterization
Stage: Prototype for research use; not cleared for commercial medical use
Headquarters: Lille, France
Founded: 2023
Intraoperative cancer tissue characterization and surgical margin assessment
2023
Biotechnology
Recorded non-equity assistance entry in public database
“CNRS / CNRS Innovation listed as institutional backer”